{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-011038","form_type":"8-K","ticker":"HEPA","cik":"0001583771","company_name":"Hepion Pharmaceuticals, Inc.","filed_at":"2025-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.077058+00:00","generated_at":"2026-05-24T10:12:04.304891+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Hepion receives Nasdaq delisting notice as bid price falls below $0.10 for 10 days","bullets":["Stock closed below $0.10 for 10 consecutive business days triggering the Low Priced Stocks Rule.","If no appeal by March 25 and $20,000 fee, delisting from Nasdaq Capital Market starts March 27, 2025.","Company intends to appeal but cannot guarantee success in continuing listing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-011038","json":"https://secwatch.observer/filing/0001493152-25-011038.json","markdown":"https://secwatch.observer/filing/0001493152-25-011038.md","text":"https://secwatch.observer/filing/0001493152-25-011038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583771/000149315225011038/0001493152-25-011038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583771/000149315225011038/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T10:12:04.304891+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"25ed59682d0af60bdb2c20a2f35e6cd523ef82ce","claim":"Hepion Pharmaceuticals, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5810(c)(3)(A)(iii)).","evidence_excerpt":"March 18, 2025, Hepion Pharmaceuticals, Inc., a Delaware corporation (the “ Company ”), received written notice (the “ Notice ”) from the Nasdaq Stock Market, LLC (“ Nasdaq ”) indicating that the bid price for the Company’s common stock (the “ Common Stock ”), for the last 10 consecutive business days, had closed below $0.10 per share and, as a result, the Company is subject to the provisions contemplated under Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”). As such, unless the Company requests an appeal of Nasdaq’s determination to delist the Company’s common stock from The Na","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315225011038/0001493152-25-011038-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5810(c)(3)(A)(iii)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}